338 related articles for article (PubMed ID: 37552392)
1. Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.
Chen X; Li X; Cao B; Chen X; Zhang K; Han F; Kan C; Zhang J; Sun X; Guo Z
Int Urol Nephrol; 2024 Feb; 56(2):571-582. PubMed ID: 37552392
[TBL] [Abstract][Full Text] [Related]
2. Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment.
Shen S; Zhong H; Zhou X; Li G; Zhang C; Zhu Y; Yang Y
Pharm Biol; 2024 Dec; 62(1):222-232. PubMed ID: 38357845
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis.
Zhang L; Miao R; Yu T; Wei R; Tian F; Huang Y; Tong X; Zhao L
Pharmacol Res; 2022 Mar; 177():106111. PubMed ID: 35183713
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.
Wu XQ; Zhao L; Zhao YL; He XY; Zou L; Zhao YY; Li X
Pharm Biol; 2024 Dec; 62(1):423-435. PubMed ID: 38757785
[TBL] [Abstract][Full Text] [Related]
5. The role of inflammation in diabetic kidney disease.
Jung SW; Moon JY
Korean J Intern Med; 2021 Jul; 36(4):753-766. PubMed ID: 34237822
[TBL] [Abstract][Full Text] [Related]
6. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention.
Ma X; Ma J; Leng T; Yuan Z; Hu T; Liu Q; Shen T
Ren Fail; 2023 Dec; 45(1):2146512. PubMed ID: 36762989
[TBL] [Abstract][Full Text] [Related]
7. Update on role of direct renin inhibitor in diabetic kidney disease.
Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
[TBL] [Abstract][Full Text] [Related]
8. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
[TBL] [Abstract][Full Text] [Related]
9. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.
Xu C; Ha X; Yang S; Tian X; Jiang H
Front Endocrinol (Lausanne); 2023; 14():1232790. PubMed ID: 37859992
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
Barrera-Chimal J; Jaisser F
Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
[TBL] [Abstract][Full Text] [Related]
11. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.
Gao Y; Su X; Xue T; Zhang N
Biomed Pharmacother; 2023 Jul; 163():114598. PubMed ID: 37150034
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
[TBL] [Abstract][Full Text] [Related]
13. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases.
Huang W; Chen YY; Li ZQ; He FF; Zhang C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142794
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease.
Liao T; Zhao K; Huang Q; Tang S; Chen K; Xie C; Zhang C; Gan W
Medicine (Baltimore); 2020 Jul; 99(31):e21137. PubMed ID: 32756091
[TBL] [Abstract][Full Text] [Related]
16. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.
Mazzieri A; Porcellati F; Timio F; Reboldi G
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612779
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in drug discovery for diabetic kidney disease.
Danta CC; Boa AN; Bhandari S; Sathyapalan T; Xu SZ
Expert Opin Drug Discov; 2021 Apr; 16(4):447-461. PubMed ID: 33003971
[TBL] [Abstract][Full Text] [Related]
18. Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy.
Wang Y; Zhao H; Wang Q; Zhou X; Lu X; Liu T; Zhan Y; Li P
J Diabetes Res; 2019; 2019():9030893. PubMed ID: 31828168
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease.
Deng L; Shi C; Li R; Zhang Y; Wang X; Cai G; Hong Q; Chen X
J Ethnopharmacol; 2024 Jun; 333():118424. PubMed ID: 38844252
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal medicine and its active compounds in attenuating renal injury
Liu P; Zhu W; Wang Y; Ma G; Zhao H; Li P
Front Endocrinol (Lausanne); 2023; 14():1142805. PubMed ID: 36942026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
